General Catalyst is a venture capital firm established in 2000 and based in San Francisco, California. The firm specializes in early-stage and growth equity investments across various sectors, including consumer, enterprise, fintech, cryptocurrency, and health assurance. By fostering an environment conducive to growth, General Catalyst aims to accelerate the development of innovative ideas and companies. The firm provides mentorship and connects clients with experienced professionals to enhance their potential for success. As a Registered Investment Adviser, General Catalyst has managed a total of eight venture capital funds, accumulating approximately $3.75 billion in capital commitments.
Two South Park Street Suite 100 San Francisco, CA 94107
434 Broadway Sixth Floor New York, NY 10013
564 University Avenue Palo Alto, CA 94301
20 University Road Fourth Floor Cambridge, MA 02138
Adrian Abeijon
Investor
Mark Allen
CFO
Neeraj Arora
Managing Director, Investment Team
Juliet Bailin
Principal
Marc Bhargava
Managing Director
Larry Bohn
Managing Director
Niko Bonatsos
Managing Director
Teresa Carlson
President, General Catalyst Institute
Kenneth Chenault
Chairman and Managing Director
Mark Crane
Partner
Joel Cutler
Co-Founder and Managing Director
Christopher Davis
Partner
Kyle Doherty
Managing Director
Nick van Eck
Partner
David Fialkow
Co-Founder and Managing Director
Bill Fitzgerald
Managing Director and COO
Diana Hong
Investor
Mina Hsiang
Associate
Nmachi Jidenma
Partner
Christopher Kauffman
Principal
Zak Kukoff
Principal
Paul Kwan
Managing Director
Karanveer Mohan
Managing Director, Investment Team
Priya Mohan
Partner, Investment Team
Deep Nishar
Managing Director
Dipchand Nishar
Managing Director
Reva Nohria
Investor
Trevor Oelschig
Managing Director
Tyler Olkowski
Investor
David Orfao
Managing Director and Co-Founder
Pranay Orugunta
Healthcare Investor
Mo Punjwani
Associate, Investments
Candace Richardson
Principal
Max Rimpel
Partner
Sam Rosen
Growth Investor
Pranav Singhvi
Partner
Bill Skarinka
Associate
Hemant Taneja
CEO and Managing Director
Alex Tran
Managing Director
Catherine Tu
Partner, Investment Team
Adam Valkin
Managing Director
Elena Viboch
Partner
Andrea Wang
Principal, Early Stage Investment
Nathaniel Levy-Westhead
Partner, Investment Team
Deep Nishar
Managing Director and Member of the Management Committee
Roy Mabrey
Partner, Investment Team
Past deals in Health Insurance
Vivere Partners
Series A in 2025
Vivere Partners is a specialty insurance company focused on tailored insurance policies.
Thatch
Series B in 2025
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Neko Health
Series B in 2025
Neko Health is a Swedish health-tech company focused on enhancing healthcare through prevention and early detection of diseases. It has developed innovative medical scanning technology that enables comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By leveraging sensor technology and artificial intelligence, Neko Health aims to reduce the prevalence of common diseases and their associated healthcare costs. The company provides doctors and clinicians with tools for flexible and cost-effective examinations, ultimately aiming to improve the quality of healthcare and promote proactive health management.
Thatch
Series A in 2024
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Transcarent
Series D in 2024
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.
Hippocratic AI
Series A in 2024
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Chamber Cardio
Seed Round in 2024
Chamber Cardio is a healthcare platform focused on enhancing cardiovascular health services by facilitating the transition of cardiologists to value-based care. The company provides a range of services, including panel management with real-time updates, financial metrics, and clinical data consolidated into a user-friendly dashboard. Additionally, it offers software support to manage complex patient cases and engages in value-based contracting. This comprehensive approach aims to improve treatment accessibility for patients and streamline operations within the healthcare sector.
Overjet
Series C in 2024
Overjet, Inc. specializes in developing artificial intelligence (AI) software aimed at enhancing dental care. Founded by experts from MIT and Harvard, the company produces clinical optimization and utilization software that analyzes dental clinical data to assess practice performance and identify growth opportunities. Its AI technology is designed to automatically review claims, highlighting instances of over and underutilization to ensure appropriate care at reduced costs. Overjet's FDA-cleared platform is the first objective standard for oral health decision-making, enabling dentists to detect pathologies accurately and communicate effectively with patients. Established in 2018, Overjet is headquartered in Allston, Massachusetts.
Fabric
Series A in 2024
Fabric is a health tech company that enables healthcare providers to deliver faster, higher quality, and more accessible care while reducing costs via consumer-grade patient experiences that automate workflows for staff.
Summa Health
Acquisition in 2024
Summa Health is a comprehensive healthcare provider that focuses on delivering integrated and coordinated care across a network of facilities. This network includes hospitals, community health centers, and a health plan, alongside a physician-hospital organization and a multi-specialty physician organization. Summa Health emphasizes personalized patient-centered care, particularly through its specialized Cancer Centers, which utilize advanced treatment technology and medical expertise to support whole-person healing. Additionally, the organization is involved in research and operates various foundations to enhance healthcare delivery and improve patient outcomes.
Harbor Health
Series A in 2024
Harbor Health is a multi-specialty clinic group based in Austin, Texas, founded in 2022. The organization focuses on delivering personalized, patient-centered healthcare by utilizing technology to enhance the patient experience. Harbor Health offers a collaborative approach to healthcare, working closely with individuals to understand their health goals and providing access to specialists when necessary. The clinic provides a variety of services, including primary care, chronic disease management, behavioral health, and overall wellness. Patients benefit from same-day and virtual appointment options, as well as conveniently located clinics, ensuring that healthcare is accessible and responsive to their needs.
Layer Health
Seed Round in 2023
Layer Health focuses on resolving the healthcare information problem by utilizing artificial intelligence to execute any clinical, administrative, or research work that involves chart review from unstructured data.
Neko Health
Series A in 2023
Neko Health is a Swedish health-tech company focused on enhancing healthcare through prevention and early detection of diseases. It has developed innovative medical scanning technology that enables comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By leveraging sensor technology and artificial intelligence, Neko Health aims to reduce the prevalence of common diseases and their associated healthcare costs. The company provides doctors and clinicians with tools for flexible and cost-effective examinations, ultimately aiming to improve the quality of healthcare and promote proactive health management.
Hippocratic AI
Seed Round in 2023
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Maribel Health
Series A in 2023
Maribel Health focuses on developing and operating advanced clinical care models that deliver healthcare services in home and community settings. The company aims to enhance the overall capacity of health systems and improve patient access by offering innovative home-based care solutions. In addition to its care models, Maribel Health provides assessment and planning services for home and community-based care, addressing the specific needs of local markets and healthcare organizations. Through these initiatives, the company seeks to facilitate better healthcare delivery and support the strategic goals of its partners.
Capital Rx
Series C in 2022
Capital Rx, Inc. is a pharmacy benefit manager that specializes in managing self-insured prescription benefit plans for employers, unions, and government entities. Founded in 2017 and headquartered in New York, the company aims to transform the pricing and administration of prescriptions in the U.S. through its innovative Clearinghouse Model, which enhances transparency in the pharmacy supply chain and reduces costs for employer groups. By integrating various components of the pharmacy ecosystem into a single platform, Capital Rx improves administrative workflows, clinical oversight, and patient-provider coordination. This approach not only increases drug price visibility but also focuses on enhancing patient outcomes and healthcare efficiency, ultimately fostering better engagement between healthcare providers and patients.
Loop
Series B in 2022
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.
Alinea Health
Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.
Avant-garde Health
Series A in 2022
Avant-garde Health, Inc. is a healthcare solutions company based in Allston, Massachusetts, founded in 2014. It specializes in developing a web-based analytics platform that assists hospitals and healthcare providers in analyzing and comparing their costs and outcomes in care delivery. The platform measures the costs of various care processes and evaluates treatment-specific data, enabling providers to learn from peer institutions and enhance their results. Avant-garde Health partners with leading healthcare providers committed to improving the value of care, offering actionable insights that facilitate better clinical decision-making and promote value-based payment models. The company was inspired by research on value-based healthcare delivery conducted at Harvard Business School.
Casana
Series B in 2022
Casana is a healthcare technology company based in Rochester, New York, that specializes in in-home cardiac health monitoring solutions. Its flagship product, the Heart Seat, is a cloud-connected toilet seat designed to allow patients to effortlessly monitor critical health metrics such as heart rate, blood pressure, blood oxygenation, and cardiac output from the comfort of their homes. The Heart Seat integrates three key sensors: a single-lead ECG for measuring the heart's electrical activity, PPG sensors that assess blood volume, and BCG sensors that track the mechanical activity of the heart. This innovative device aims to assist medical teams in managing chronic conditions by providing continuous, reliable health data outside traditional healthcare settings. Casana's technology is focused on fostering proactive health management and improving patient outcomes.
Transcarent
Series C in 2022
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.
Overjet
Series B in 2021
Overjet, Inc. specializes in developing artificial intelligence (AI) software aimed at enhancing dental care. Founded by experts from MIT and Harvard, the company produces clinical optimization and utilization software that analyzes dental clinical data to assess practice performance and identify growth opportunities. Its AI technology is designed to automatically review claims, highlighting instances of over and underutilization to ensure appropriate care at reduced costs. Overjet's FDA-cleared platform is the first objective standard for oral health decision-making, enabling dentists to detect pathologies accurately and communicate effectively with patients. Established in 2018, Overjet is headquartered in Allston, Massachusetts.
Ribbon Health
Series B in 2021
Ribbon Health, Inc. operates a software as a service (SaaS) platform that delivers essential data on healthcare providers, insurance plans, and the quality and cost of care. The platform includes features such as provider directories, referral management, care navigation, and insurance enrollment. Ribbon Health serves various clients, including health insurance companies, third-party administrators, clinics, hospitals, and digital health solutions. The company was incorporated in 2016 and is headquartered in New York, New York. Originally named HealthWiz, Inc., it rebranded to Ribbon Health, Inc. in March 2018.
Color
Series E in 2021
Color is a healthcare technology company that provides a comprehensive platform for managing large-scale health initiatives, including population genomics and COVID-19 testing. The company focuses on delivering equitable and accessible healthcare programs tailored for businesses, schools, and public health departments. By centralizing essential healthcare capabilities, Color addresses logistical challenges and enhances the delivery of preventive care. Its offerings facilitate a range of services, from testing and screening to treatment and referrals, thereby supporting clinical teams in effectively managing public health across diverse populations. Through its innovative model, Color aims to improve health outcomes and create sustainable revenue streams while ensuring that quality healthcare is available to all.
Better Health
Series A in 2021
Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.
Loop
Series A in 2021
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.
Overjet
Series A in 2021
Overjet, Inc. specializes in developing artificial intelligence (AI) software aimed at enhancing dental care. Founded by experts from MIT and Harvard, the company produces clinical optimization and utilization software that analyzes dental clinical data to assess practice performance and identify growth opportunities. Its AI technology is designed to automatically review claims, highlighting instances of over and underutilization to ensure appropriate care at reduced costs. Overjet's FDA-cleared platform is the first objective standard for oral health decision-making, enabling dentists to detect pathologies accurately and communicate effectively with patients. Established in 2018, Overjet is headquartered in Allston, Massachusetts.
Transcarent
Series B in 2021
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.
ixlayer
Series A in 2021
ixlayer is a prominent player in the health-tech sector, specializing in virtual health testing solutions for health systems, payors, biopharma, and health-focused organizations. Founded in 2018, the company provides a comprehensive platform that addresses the technical, security, regulatory, and user experience aspects of complex health testing. As the healthcare landscape increasingly embraces remote care, ixlayer enhances patient engagement and supports preventative health strategies through scalable virtual testing options. The platform can be integrated into existing patient engagement systems and portals, facilitating real-time health and wellness lab testing. ixlayer currently serves millions of patients and has successfully launched numerous testing programs for major organizations, health systems, and government entities.
Circulo
Series A in 2021
Circulo Health is a Medicaid insurance company of the future, providing tech-enabled care to the sickest and poorest populations. Circulo is based in Columbus, Ohio, the emerging insurtech capital of the U.S.
Casana
Series A in 2021
Casana is a healthcare technology company based in Rochester, New York, that specializes in in-home cardiac health monitoring solutions. Its flagship product, the Heart Seat, is a cloud-connected toilet seat designed to allow patients to effortlessly monitor critical health metrics such as heart rate, blood pressure, blood oxygenation, and cardiac output from the comfort of their homes. The Heart Seat integrates three key sensors: a single-lead ECG for measuring the heart's electrical activity, PPG sensors that assess blood volume, and BCG sensors that track the mechanical activity of the heart. This innovative device aims to assist medical teams in managing chronic conditions by providing continuous, reliable health data outside traditional healthcare settings. Casana's technology is focused on fostering proactive health management and improving patient outcomes.
Capital Rx
Series B in 2021
Capital Rx, Inc. is a pharmacy benefit manager that specializes in managing self-insured prescription benefit plans for employers, unions, and government entities. Founded in 2017 and headquartered in New York, the company aims to transform the pricing and administration of prescriptions in the U.S. through its innovative Clearinghouse Model, which enhances transparency in the pharmacy supply chain and reduces costs for employer groups. By integrating various components of the pharmacy ecosystem into a single platform, Capital Rx improves administrative workflows, clinical oversight, and patient-provider coordination. This approach not only increases drug price visibility but also focuses on enhancing patient outcomes and healthcare efficiency, ultimately fostering better engagement between healthcare providers and patients.
Story Health
Seed Round in 2020
Story Health Corporation, founded in 2020 and based in Saratoga, California, develops advanced virtualized clinical care software tools aimed at aiding healthcare specialists, particularly neurologists and primary care physicians. The company offers a comprehensive healthcare technology platform that includes virtual patient programs, therapy management, and analytics designed to bridge the gap between clinical evidence and patient experiences. By utilizing data from high-frequency sources, Story Health empowers clinicians to better understand medical situations and make informed decisions regarding the physiological impacts of diseases and therapies. Through its innovative approach, Story Health enhances the ability of specialists to deliver effective patient care.
Transcarent
Series A in 2020
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.
Oscar Health
Venture Round in 2020
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Oscar Health
Venture Round in 2018
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Avant-garde Health
Seed Round in 2018
Avant-garde Health, Inc. is a healthcare solutions company based in Allston, Massachusetts, founded in 2014. It specializes in developing a web-based analytics platform that assists hospitals and healthcare providers in analyzing and comparing their costs and outcomes in care delivery. The platform measures the costs of various care processes and evaluates treatment-specific data, enabling providers to learn from peer institutions and enhance their results. Avant-garde Health partners with leading healthcare providers committed to improving the value of care, offering actionable insights that facilitate better clinical decision-making and promote value-based payment models. The company was inspired by research on value-based healthcare delivery conducted at Harvard Business School.
Color
Series C in 2017
Color is a healthcare technology company that provides a comprehensive platform for managing large-scale health initiatives, including population genomics and COVID-19 testing. The company focuses on delivering equitable and accessible healthcare programs tailored for businesses, schools, and public health departments. By centralizing essential healthcare capabilities, Color addresses logistical challenges and enhances the delivery of preventive care. Its offerings facilitate a range of services, from testing and screening to treatment and referrals, thereby supporting clinical teams in effectively managing public health across diverse populations. Through its innovative model, Color aims to improve health outcomes and create sustainable revenue streams while ensuring that quality healthcare is available to all.
Color
Series B in 2016
Color is a healthcare technology company that provides a comprehensive platform for managing large-scale health initiatives, including population genomics and COVID-19 testing. The company focuses on delivering equitable and accessible healthcare programs tailored for businesses, schools, and public health departments. By centralizing essential healthcare capabilities, Color addresses logistical challenges and enhances the delivery of preventive care. Its offerings facilitate a range of services, from testing and screening to treatment and referrals, thereby supporting clinical teams in effectively managing public health across diverse populations. Through its innovative model, Color aims to improve health outcomes and create sustainable revenue streams while ensuring that quality healthcare is available to all.
Brighter
Series D in 2016
Brighter, Inc. is a technology-driven company based in Santa Monica, California, that specializes in providing a platform connecting patients, providers, and payers. Founded in 2010, Brighter offers consumer-focused dental benefits tailored for employees of self-insured companies and licenses its engagement platforms to large insurance carriers. The company aims to transform the health insurance landscape by empowering patients to become active healthcare consumers through a seamless online and mobile experience. By leveraging technology to streamline interactions and reduce administrative costs, Brighter pre-negotiates rates for common dental procedures within its network of approved dentists, facilitating affordable and convenient access to healthcare services. As a subsidiary of Cigna Corporation, Brighter combines expertise from various industries, including health insurance and technology, to enhance the consumer experience in healthcare.
Oscar Health
Private Equity Round in 2016
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Oscar Health
Series C in 2015
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Oscar Health
Series B in 2014
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Oscar Health
Series A in 2014
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Oscar Health
Series A in 2013
Oscar Health is a health insurance company that offers a range of plans for individuals, families, and small groups, as well as Medicare Advantage options for adults aged 65 and older. Founded in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, the company is headquartered in New York City. Oscar Health employs technology and data-driven solutions to enhance the healthcare experience, providing virtual care, doctor support, and appointment scheduling services. Its plans are available in select regions of New York, New Jersey, California, and Texas, catering to those who do not receive employer-sponsored health insurance.
Aidin
Venture Round in 2012
Aidin is a healthcare technology company focused on enhancing the discharge planning process for hospitals and social workers. Its platform streamlines the workflow for discharge planning professionals by automating the generation of provider listings, thereby minimizing administrative tasks and allowing social workers to concentrate more on patient care. Aidin provides patients with access to quality ratings and reviews of available post-acute care providers, facilitating informed decision-making. The platform also tracks patient experiences and outcomes, equipping case managers with valuable insights to identify the most effective providers for specific health conditions. By connecting patients with the right post-hospital care options, Aidin aims to reduce readmissions and improve overall patient satisfaction.
Humedica
Venture Round in 2012
Humedica is a clinical intelligence company that specializes in health analytics, providing tools for hospitals, physicians, and life sciences organizations. The company's primary offering, Humedica MinedShare, is a platform designed to transform unconnected data from various sources into actionable insights, enabling clients to make better-informed decisions. By facilitating clinical, operational, and financial benchmarking across the continuum of care, Humedica supports healthcare providers in enhancing the quality and efficiency of their services.
Humedica
Venture Round in 2011
Humedica is a clinical intelligence company that specializes in health analytics, providing tools for hospitals, physicians, and life sciences organizations. The company's primary offering, Humedica MinedShare, is a platform designed to transform unconnected data from various sources into actionable insights, enabling clients to make better-informed decisions. By facilitating clinical, operational, and financial benchmarking across the continuum of care, Humedica supports healthcare providers in enhancing the quality and efficiency of their services.
Humedica
Series A in 2009
Humedica is a clinical intelligence company that specializes in health analytics, providing tools for hospitals, physicians, and life sciences organizations. The company's primary offering, Humedica MinedShare, is a platform designed to transform unconnected data from various sources into actionable insights, enabling clients to make better-informed decisions. By facilitating clinical, operational, and financial benchmarking across the continuum of care, Humedica supports healthcare providers in enhancing the quality and efficiency of their services.
Imprivata
Series C in 2008
Imprivata, Inc. is a provider of information technology security and identity solutions specifically designed for the healthcare industry. Headquartered in Lexington, Massachusetts, the company offers a comprehensive platform that addresses security and compliance challenges faced by healthcare organizations. Key products include Imprivata OneSign, which integrates single sign-on and authentication management to streamline access to workstations and applications; Imprivata Cortext, a secure messaging platform that enables compliant communication among healthcare providers; and Imprivata Confirm ID, which simplifies identity proofing and enforces two-factor authentication for electronic health records. Additionally, Imprivata PatientSecure enhances patient safety by reducing duplicate medical records and identity-related fraud. The company's solutions are utilized in over 45 countries, supporting healthcare organizations in managing and securing digital identities effectively. Founded in 2001, Imprivata remains committed to improving the efficiency and security of healthcare workflows.
Imprivata
Series B in 2006
Imprivata, Inc. is a provider of information technology security and identity solutions specifically designed for the healthcare industry. Headquartered in Lexington, Massachusetts, the company offers a comprehensive platform that addresses security and compliance challenges faced by healthcare organizations. Key products include Imprivata OneSign, which integrates single sign-on and authentication management to streamline access to workstations and applications; Imprivata Cortext, a secure messaging platform that enables compliant communication among healthcare providers; and Imprivata Confirm ID, which simplifies identity proofing and enforces two-factor authentication for electronic health records. Additionally, Imprivata PatientSecure enhances patient safety by reducing duplicate medical records and identity-related fraud. The company's solutions are utilized in over 45 countries, supporting healthcare organizations in managing and securing digital identities effectively. Founded in 2001, Imprivata remains committed to improving the efficiency and security of healthcare workflows.
Imprivata
Series A in 2005
Imprivata, Inc. is a provider of information technology security and identity solutions specifically designed for the healthcare industry. Headquartered in Lexington, Massachusetts, the company offers a comprehensive platform that addresses security and compliance challenges faced by healthcare organizations. Key products include Imprivata OneSign, which integrates single sign-on and authentication management to streamline access to workstations and applications; Imprivata Cortext, a secure messaging platform that enables compliant communication among healthcare providers; and Imprivata Confirm ID, which simplifies identity proofing and enforces two-factor authentication for electronic health records. Additionally, Imprivata PatientSecure enhances patient safety by reducing duplicate medical records and identity-related fraud. The company's solutions are utilized in over 45 countries, supporting healthcare organizations in managing and securing digital identities effectively. Founded in 2001, Imprivata remains committed to improving the efficiency and security of healthcare workflows.
GTESS Corp
Series B in 2005
GTESS provides an outsourced front-end solution including paper, web and EDI claims conversion and cleaning, correspondence and non-standard claim management, coordination of benefits (including Medicare), repricing facilitation and a full document management solution. Their core systems feature years of progressive functionality based on solid artificial intelligence and neural net technology. They operate in partnership with leading healthcare payers and networks in the country. Helping TPAs, PPOs and HMOs outsource their front-end operations to gain quality and service improvements while focusing on strategic initiatives and positively impacting their bottom line.
GTESS Corp
Series A in 2004
GTESS provides an outsourced front-end solution including paper, web and EDI claims conversion and cleaning, correspondence and non-standard claim management, coordination of benefits (including Medicare), repricing facilitation and a full document management solution. Their core systems feature years of progressive functionality based on solid artificial intelligence and neural net technology. They operate in partnership with leading healthcare payers and networks in the country. Helping TPAs, PPOs and HMOs outsource their front-end operations to gain quality and service improvements while focusing on strategic initiatives and positively impacting their bottom line.
Imprivata
Series A in 2002
Imprivata, Inc. is a provider of information technology security and identity solutions specifically designed for the healthcare industry. Headquartered in Lexington, Massachusetts, the company offers a comprehensive platform that addresses security and compliance challenges faced by healthcare organizations. Key products include Imprivata OneSign, which integrates single sign-on and authentication management to streamline access to workstations and applications; Imprivata Cortext, a secure messaging platform that enables compliant communication among healthcare providers; and Imprivata Confirm ID, which simplifies identity proofing and enforces two-factor authentication for electronic health records. Additionally, Imprivata PatientSecure enhances patient safety by reducing duplicate medical records and identity-related fraud. The company's solutions are utilized in over 45 countries, supporting healthcare organizations in managing and securing digital identities effectively. Founded in 2001, Imprivata remains committed to improving the efficiency and security of healthcare workflows.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.